NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-11-03 20:37இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Halder Venture Limited submitted its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The notes disclose multiple non-routine items, including 7,93,650 equity warrants allotted at Rs 315 per warrant (receiving Rs 625 lakhs upfront) and Rs 56.14 crore (Rs 5,614.09 lakhs) in ROU assets for acquired leasehold land from K.S. Oils (in liquidation) awaiting title transfer. Additionally, subsidiary holdings of 6.62% in the parent contravene Section 19 of the Companies Act, which the company aims to dispose of, and consolidated results incorporated unreviewed numbers from certain African and related entities.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுBoard approved Q2 and H1 FY27 unaudited financial results with limited review reports, accompanied by detailed accounting notes on ongoing land/property litigation and unreviewed foreign subsidiary figures.
ஏன் இது முக்கியம்Provides updates on key capital allocation moves (Haldia asset acquisition of Rs 56.14 crore) and highlights governance/statutory compliance items including cross-holding divestment and unreviewed overseas entities.
Warrants allotted: 7,93,650Warrant issue price: Rs. 315 per warrantUpfront warrant proceeds received: Rs. 625 lakhsAcquired leasehold land value (ROU asset): Rs. 5614.09 lakhsCapital advance in litigation (Mumbai office): Rs. 608 lakhsSubsidiary shareholding in contravention of Sec 19: 6.62%
📅 குறுகிய காலம்Market attention will focus on the exact quarterly earnings performance and the audit notes highlighting Section 19 non-compliance and unreviewed foreign subsidiary accounts.
📈 நீண்ட காலம்Resolution of title transfers for the Haldia industrial unit and resolution of disputed Mumbai real estate will determine asset productivity.
⚠ அபாய எச்சரிக்கைகள்
Contravention of Section 19 of the Companies Act due to subsidiaries holding parent company shares.
Consolidated results include unreviewed figures for step-down overseas subsidiaries and LLC Halroots.
👀 கவனிக்க வேண்டியவை
Track the full P&L tables when released on exchange disclosures, the timeline of subsidiary share divestments to cure Section 19 contravention, and the regularisation of overseas subsidiary audit reviews.
Halder Venture Q2 Standalone PAT Jumps to ₹4.05 Cr vs ₹1.06 Cr YoY; Revenue at ₹228.06 Cr
Halder Venture reported standalone revenue from operations of ₹228.06 crore for Q2 FY27 (quarter ended September 30, 2026), up significantly from ₹52.17 crore in Q2 FY26. Standalone net profit stood at ₹4.05 crore compared to ₹1.06 crore in the year-ago period, though down from ₹5.61 crore in Q1 FY27. The company received ₹6.25 crore (25% upfront) towards the preferential allotment of 7,93,650 convertible warrants issued at ₹315 per warrant. Additionally, consolidated results incorporated unaudited figures from key overseas subsidiaries and entities as auditor reviews were incomplete.
உச்சம் நம்பிக்கை
என்ன மாறியதுHalder Venture reported Q2 FY27 results showing strong YoY top-line recovery, alongside updates on warrant capital infusion and ongoing governance/auditing delays in overseas units.
ஏன் இது முக்கியம்Topline execution has rebounded compared to a weak FY26 base, but heavy debt (standalone borrowings exceeding ₹413 cr vs market cap of ₹392 cr) and unaudited subsidiary contributions pose operational and reporting concerns.
Standalone Revenue (Q2): ₹22,805.81 லட்சம்Standalone Net Profit (Q2): ₹404.58 லட்சம்Warrant upfront received: ₹625 லட்சம்Warrant issue price: ₹315 per warrantTotal Standalone Borrowings: ₹41,344.99 லட்சம்
📅 குறுகிய காலம்Market may weigh strong top-line and YoY profit recovery against QoQ margin compression and auditor caveats on subsidiaries.
📈 நீண்ட காலம்Working capital discipline and leverage management are critical given high debt levels relative to modest operating margins.
⚠ அபாய எச்சரிக்கைகள்
Subsidiaries (Hal Exim Pte and LLC Halroots) included without independent auditor reviews
Litigation on Mumbai commercial asset impacting clear title for ₹608 lakhs advance
High standalone leverage with total borrowings at ₹413.45 crore
👀 கவனிக்க வேண்டியவை
Track subsequent filings for the completion of the limited review reports for overseas subsidiaries and watch for resolution of title disputes on the ₹6.08 crore Mumbai commercial property advance.
Halder Venture Q1 Revenue up 69% YoY; Auditors flag Rs 66.8 Cr non-moving inventory
Halder Venture reported a strong 68.7% YoY growth in standalone revenue to Rs 180.01 Cr for Q1 FY27, with net profit rising 42.7% to Rs 5.61 Cr. However, the statutory auditors highlighted significant concerns regarding Rs 66.83 Cr of inventory (Rice and Rice Bran Oil) that has been non-moving for over two years and is still carried at cost. The Edible Oil segment has become the primary driver, contributing 76.8% of consolidated revenue, while the Rice segment reported a loss of Rs 2.02 Cr at the segment result level.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has shown significant revenue growth driven by its Edible Oil segment, but auditors have raised formal concerns regarding inventory valuation and asset depreciation methods.
ஏன் இது முக்கியம்The flagged non-moving inventory represents approximately 27.7% of the company's current market capitalization, making its realization value critical for the company's net worth and future earnings.
📅 குறுகிய காலம்The market may react positively to the top-line growth, but the auditor's emphasis of matter regarding legacy inventory and depreciation could cap gains as it introduces valuation uncertainty.
📈 நீண்ட காலம்Structural growth depends on the successful scaling of the Edible Oil business and the resolution of legacy asset issues inherited from liquidations.
⚠ அபாய எச்சரிக்கைகள்
Inventory write-down risk (Rs 66.83 Cr non-moving for 2+ years)
Auditor qualification on depreciation of old plant assets
Loss-making Rice segment (Rs 2.02 Cr loss in Q1)
High finance costs relative to operating margins
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the management's progress in liquidating the Rs 66.83 Cr non-moving inventory, as any significant write-down would impact the bottom line. Additionally, watch for the technical evaluation of the old plant assets (Rs 1.43 Cr) acquired from K.S. Oils, expected by the next quarter.
Halder Venture Seeks Shareholder Approval for Rs 1,000 Cr Borrowing and Investment Limits
Halder Venture Limited has issued a notice for its 44th Annual General Meeting (AGM) on September 7, 2026. The most significant agenda item is a proposal to increase both borrowing limits and investment/loan limits to Rs 1,000 Crores each, which is nearly 3x the company's TTM revenue of Rs 346 Cr. Additionally, the company seeks to appoint new statutory auditors for a 5-year term and approve a commission of up to 1% of net profits for a Non-Executive Director. These moves signal a potential for massive capital expenditure or expansion relative to the company's current Rs 238 Cr market capitalization.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company is seeking shareholder permission to significantly expand its financial headroom for borrowing and investing, moving from current levels to a cap of Rs 1,000 Crores.
ஏன் இது முக்கியம்The proposed Rs 1,000 Cr limit is highly material as it represents ~420% of the company's current market cap and ~289% of its TTM revenue, suggesting a major shift in business scale or potential acquisitions.
Proposed Borrowing Limit: Rs 1,000 CroresProposed Investment Limit: Rs 1,000 CroresLimit vs TTM Revenue: ~289%Limit vs Market Cap: ~420%Director Commission Cap: 1% of net profits
📅 குறுகிய காலம்The market may react with caution or curiosity to the scale of the proposed limits; the immediate focus will be on the AGM outcome and management's justification for such high limits.
📈 நீண்ட காலம்If the company utilizes these limits for high-return projects, it could lead to a structural re-rating; however, the current low operating margin of 2.2% makes execution and interest coverage key risks.
⚠ அபாய எச்சரிக்கைகள்
High borrowing limit relative to current revenue and market cap
Potential for significant debt-servicing burden
Low operating margins (2.2%) may limit the ability to absorb high interest costs
👀 கவனிக்க வேண்டியவை
Investors should monitor the voting results of the AGM on September 7, 2026, particularly for the special resolution on borrowing limits, and watch for any subsequent announcements regarding specific expansion projects or debt-raising plans.
Halder Venture Limited has approved the allotment of 7,93,650 equity convertible warrants to P.K. Bio Link Private Limited, a non-promoter entity. The warrants are issued at Rs 315 each, which is a significant ~36% premium over the current market price of Rs 231. The total fundraise is valued at approximately Rs 25 crore, representing about 12.8% of the company's current market capitalization. The company has already received the mandatory 25% upfront subscription amount (approx. Rs 6.25 crore).
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has successfully initiated a preferential fundraise from a non-promoter investor, securing an immediate capital inflow of approximately Rs 6.25 crore.
ஏன் இது முக்கியம்This fundraise provides significant growth capital relative to the company's size (12.8% of market cap) and the high premium suggests strong external valuation support for the stock.
Total Warrants Allotted: 7,93,650Issue Price per Warrant: Rs 315Total Fundraise Value: Rs 25 கோடிFundraise vs Market Cap: ~12.8%Upfront Amount Received (25%): ~Rs 6.25 Cr
📅 குறுகிய காலம்The announcement is likely to be viewed positively by the market due to the substantial premium of the warrant price over the current market price.
📈 நீண்ட காலம்If the capital is deployed into high-margin agricultural processing or expansion, it could improve the current low OPM of 2.2% and drive earnings growth.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution of approximately 12-13% upon full conversion of warrants
Concentration risk with a single non-promoter allottee
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's disclosure regarding the specific use of these funds and the timeline for the remaining 75% payment and subsequent conversion into equity shares.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Halder Venture Limited responded to an NSE query, confirming an unmodified audit opinion for FY26. The filing reveals a legal contravention where two subsidiaries hold a 6.61% stake (8,22,654 shares) in the parent company, which they are currently divesting. Materially, the company disclosed the acquisition of the Haldia Manufacturing Unit for Rs 56.14 crore and an additional development spend of Rs 44.30 crore. Furthermore, a preferential allotment of 7,93,650 convertible warrants at Rs 315 per warrant is underway to raise capital.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company provided formal proof of its audit opinion filing and detailed a significant legal non-compliance regarding subsidiary shareholding.
ஏன் இது முக்கியம்The Section 19 violation is a compliance risk, while the ~Rs 100 crore total investment in the Haldia unit is substantial relative to the company's Rs 195 crore market cap, indicating a major pivot or expansion.
Subsidiary Cross-holding: 6.61%Haldia Unit Acquisition Cost: Rs 56.14 கோடிDevelopment Spend on Property: Rs 44.30 கோடிWarrant Issue Price: Rs 315Acquisition vs TTM Revenue: 16.2%
📅 குறுகிய காலம்The stock may see volatility as the market weighs the legal non-compliance against the significant asset expansion and upcoming warrant dilution.
📈 நீண்ட காலம்The successful integration and scaling of the Haldia unit could structurally change the company's revenue profile, given the scale of investment relative to current operations.
⚠ அபாய எச்சரிக்கைகள்
Legal contravention of Section 19 of Companies Act
Execution risk on the newly acquired Haldia unit
Equity dilution from 7.93 lakh convertible warrants
👀 கவனிக்க வேண்டியவை
Investors should monitor the timeline for the disposal of the 6.61% stake by subsidiaries to resolve the legal contravention and track the operationalization of the Haldia unit for revenue contribution.
Halder Venture: Credit Rating Upgraded to CRISIL BBB-/Stable for Rs 387.27 Cr Facilities
CRISIL has upgraded Halder Venture's long-term credit rating to 'BBB-/Stable' from 'BB+/Stable ISSUER NOT COOPERATING'. This upgrade applies to total bank loan facilities of Rs 387.27 crore, which is significant given the company's TTM revenue of Rs 346 crore. The short-term rating has been reassigned as 'CRISIL A3'. The removal of the 'Issuer Not Cooperating' status indicates improved transparency and better standing with financial institutions.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company's credit rating migrated from a non-cooperative 'BB+' grade to an investment-grade 'BBB-' rating by CRISIL.
ஏன் இது முக்கியம்Moving into investment grade and out of 'non-cooperating' status improves the company's ability to negotiate better interest rates and access fresh capital, which is critical given its high debt-to-revenue ratio.
Total Bank Facilities: Rs 387.27 கோடிRated Debt vs TTM Revenue: ~112%Long Term Rating: CRISIL BBB-/StableProposed Term Loan: Rs 13.07 கோடிTTM வருவாய்: Rs 346 கோடி
📅 குறுகிய காலம்The upgrade is likely to be viewed positively by the market in the short term as it validates the company's financial reporting and creditworthiness.
📈 நீண்ட காலம்While the upgrade is a structural positive, the company's low operating margin (2.2%) and high debt relative to revenue remain key long-term monitoring points.
⚠ அபாய எச்சரிக்கைகள்
High leverage (Debt exceeds TTM Revenue)
Low operating margins (2.2%)
Concentration of debt in Cash Credit facilities (Rs 316 Cr)
👀 கவனிக்க வேண்டியவை
Monitor upcoming quarterly results to see if this upgrade leads to a reduction in finance costs. Watch for the utilization of the Rs 13.07 crore proposed term loan as a signal for potential expansion.
Halder Venture Limited has received in-principle approval from both NSE and BSE for the issuance of 7,93,650 convertible warrants. These warrants are to be issued to non-promoters on a preferential basis at a price not less than Rs 315 per warrant, representing a total capital infusion of approximately Rs 25 crore. This fundraise is significant as it represents nearly double the company's TTM PAT of Rs 13 crore. The warrants are convertible into equity shares of Rs 10 each on a 1:1 basis within the regulatory timeframe.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has secured the necessary regulatory 'in-principle' approvals from stock exchanges to proceed with its planned preferential issuance of convertible warrants.
ஏன் இது முக்கியம்A Rs 25 crore capital infusion is material for a company with a TTM revenue of Rs 346 crore and low margins, providing necessary liquidity for potential expansion or strengthening the balance sheet.
Warrants to be issued: 7,93,650Minimum Issue Price: Rs 315Estimated Fundraise: Rs 25 கோடிFundraise vs TTM Revenue: ~7.2%Fundraise vs TTM PAT: ~192%
📅 குறுகிய காலம்The stock may see positive sentiment as the regulatory hurdle for capital infusion is cleared, though the actual impact depends on the final allotment and investor profile.
📈 நீண்ட காலம்The structural impact depends on whether the management can deploy this capital to stabilize earnings, which have been volatile (ranging from a Rs 10.8 cr loss to a Rs 20.7 cr profit in recent quarters).
⚠ அபாய எச்சரிக்கைகள்
Equity dilution for existing shareholders
Low operating profit margin (2.2%)
Historical earnings volatility
👀 கவனிக்க வேண்டியவை
Investors should monitor the final allotment notification to identify the specific non-promoter entities and watch for subsequent disclosures regarding the utilization of these funds to improve the current 2.2% operating margins.
Halder Venture Limited has approved its audited financial results for the fiscal year ended March 31, 2026. A major highlight is the board's proposal to increase the company's borrowing limits and investment/loan limits to ₹1,000 crores each, pending shareholder approval. The company is also undergoing a statutory auditor transition, proposing P. Somani & Co. for a five-year term as the current auditor's tenure concludes. These structural and financial limit changes suggest the company is positioning itself for significant capital deployment or expansion.
முக்கிய அம்சங்கள்
Approved standalone and consolidated audited financial results for the quarter and year ended March 31, 2026.Proposed a significant increase in borrowing limits up to ₹1,000 crores under Section 180(1)(c).Proposed increasing limits for providing loans, guarantees, and investments up to ₹1,000 crores under Section 186.Recommended the appointment of M/s P. Somani & Co. as Statutory Auditors for a 5-year term starting from the 44th AGM.Reappointed J Kumar Jain & Associates as Internal Auditors and J Pal & Co as Cost Auditors for FY 2026-27.
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the specific reasons for the massive hike in borrowing limits to ₹1,000 crores, as this may precede a major acquisition or expansion phase. It is also essential to review the full audited financial report to evaluate the company's current debt-to-equity ratio before these new limits are utilized.
Halder Venture Revises Valuation Report for Preferential Issue of 7.93 Lakh Warrants
Halder Venture Limited has submitted a revised valuation report for its proposed preferential issue of 7,93,650 convertible warrants. The revision was triggered by observations from the NSE and BSE, which classified the company's equity shares as "frequently traded shares." This classification requires a valuation update in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The update ensures regulatory compliance for the capital raising process initiated on May 13, 2026.
முக்கிய அம்சங்கள்
Proposed preferential issue involves 7,93,650 Convertible Warrants.Revision follows NSE and BSE classification of shares as 'frequently traded'.Valuation updated to comply with Chapter V of SEBI ICDR Regulations.The company has uploaded the full revised valuation report to its official website for transparency.
👀 கவனிக்க வேண்டியவை
Investors should check the revised valuation report on the company's website to see if the warrant pricing has changed. Monitor for further updates on the final allotment and the intended use of the raised capital.
Halder Venture Revises Compliance for Preferential Issue of 7.93 Lakh Warrants
Halder Venture Limited has submitted revised compliance documents regarding its proposed preferential issue of 7,93,650 convertible warrants. The revision follows observations from the National Stock Exchange (NSE) which led to the classification of the company's equity shares as "frequently traded shares." Consequently, the company has updated its Compliance Certificate to align with SEBI (Issue of Capital and Disclosure Requirements) Regulations. This procedural update is necessary to move forward with the planned capital infusion.
முக்கிய அம்சங்கள்
Proposed preferential issue of 7,93,650 Convertible Warrants to raise capital.NSE observations led to the reclassification of shares as "frequently traded shares."Revised Compliance Certificate submitted to ensure adherence to SEBI ICDR Regulations.The update follows a previous disclosure made on May 13, 2026.
👀 கவனிக்க வேண்டியவை
Investors should monitor the final pricing and conversion terms of the warrants, as the 'frequently traded' status may impact the valuation. No immediate action is required as this is a regulatory compliance update.
Halder Venture Updates Pricing Basis for 7.93 Lakh Warrant Issue Following NSE Observation
Halder Venture Limited has updated the classification of its equity shares from infrequently traded to frequently traded for its proposed preferential issue of 7,93,650 convertible warrants. This change follows observations from the National Stock Exchange (NSE) regarding SEBI ICDR Regulations. Despite the reclassification, the company confirmed that the issue price remains unchanged from the original postal ballot notice dated March 26, 2026. The pricing continues to be supported by a valuation report from a Registered Valuer under Regulation 166A.
முக்கிய அம்சங்கள்
Proposed issuance of 7,93,650 convertible warrants on a preferential basisShares reclassified as frequently traded following NSE observation dated May 12, 2026Issue price remains unchanged despite the change in trading frequency classificationShareholder approval for the issue was previously secured via postal ballot on April 30, 2026
👀 கவனிக்க வேண்டியவை
Investors should note that the fundraising process is proceeding with regulatory alignment. No change in the issue price suggests that the valuation remains consistent with the registered valuer's assessment.
Halder Venture Shareholders Approve Capital Increase and Preferential Warrant Issue
Halder Venture Limited has received overwhelming shareholder approval for two major resolutions via postal ballot. The first resolution involves increasing the company's Authorized Share Capital, which passed with 99.9998% support. The second resolution, passed with 99.9973% support, authorizes the issuance of fully convertible warrants on a preferential basis to non-promoter entities. This indicates strong shareholder backing for the company's upcoming capital infusion and expansion plans.
முக்கிய அம்சங்கள்
Resolution to increase Authorized Share Capital passed with 9,537,125 votes (99.9998%) in favor.Issuance of fully convertible warrants to non-promoters approved with 9,536,878 votes (99.9973%) in favor.A total of 79 members participated in the remote e-voting process which concluded on April 29, 2026.The approval allows the company to proceed with preferential allotment to non-promoter categories for fund raising.
👀 கவனிக்க வேண்டியவை
Investors should monitor the specific pricing and allotment details of the convertible warrants to understand the extent of equity dilution and the profile of the new investors entering the company.
Halder Venture Issues 2nd Corrigendum for 7.93 Lakh Warrant Issue at ₹315
Halder Venture Limited has issued a second corrigendum to its postal ballot notice regarding the preferential issue of 7,93,650 convertible warrants. The issue price is fixed at ₹315 per warrant, which includes a premium of ₹305, based on an independent valuation of ₹314.79. This update follows observations from the National Stock Exchange (NSE) to ensure compliance with SEBI ICDR Regulations for infrequently traded shares. The proposed allotment will result in the allottee holding more than 5% of the post-issue fully diluted share capital.
முக்கிய அம்சங்கள்
Preferential issue of 7,93,650 convertible warrants at a price of ₹315 per warrant.Independent valuation report by CA Sanjay Jhajharia determined a floor price of ₹314.79.Corrigendum issued to comply with SEBI ICDR Regulations 165 and 166A(1) following NSE observations.The allotment will exceed 5% of the post-issue fully diluted share capital of the company.Shareholders who have already voted can submit comments to the Company Secretary until April 26, 2026.
👀 கவனிக்க வேண்டியவை
Investors should review the valuation justification provided for this infrequently traded stock and monitor the impact of the 5% plus dilution on the capital structure. No immediate action is required unless shareholders wish to revise their feedback based on the new disclosures.
Halder Venture to Raise Rs 25 Cr via 7.94 Lakh Warrants for Haldia Unit Expansion
Halder Venture Limited is raising approximately Rs 25 crore through the issuance of 7,93,650 convertible warrants at Rs 315 per warrant to P.K. Bio Link Private Limited. The proceeds are primarily earmarked for a new 500 MT edible oil refining unit in Haldia (Rs 11.50 crore) and augmenting working capital (Rs 11.30 crore). The company also aims to increase its rice mill capacity utilization from 50% to 80% to serve expanding foreign markets. This corrigendum provides necessary clarifications on pricing and fund utilization as requested by NSE and BSE.
முக்கிய அம்சங்கள்
Issuance of 7,93,650 convertible warrants at Rs 315 per warrant to raise ~Rs 25 crore.Allocation of Rs 11.50 crore for a new 500 MT edible oil refining unit at the Haldia facility.Plan to increase rice mill capacity utilization from 50% to 70-80% to meet export demand.P.K. Bio Link Private Limited to hold a 5.99% stake in the company post-conversion.Funds to be utilized within 6 months of receipt for capital expansion and working capital.
👀 கவனிக்க வேண்டியவை
Investors should track the execution of the Haldia refining unit as it marks a significant capacity expansion into the edible oil sector. Monitor the warrant conversion process over the next 18 months for potential equity dilution.
Halder Venture Credit Rating Upgraded to 'CRISIL BBB-/Stable' on Improved Financial Performance
CRISIL has upgraded Halder Venture Limited's long-term rating to 'CRISIL BBB-/Stable' from 'CRISIL BB+/Stable (Issuer Not Cooperating)' following improved data transparency and strong financial growth. The company reported a significant revenue jump to Rs 870.88 crore in FY25, with PAT nearly doubling to Rs 21.11 crore. While the group maintains a moderate financial risk profile with a gearing of 1.94x, it is currently executing a large Rs 155 crore capex for a new refinery and storage unit in Haldia. Liquidity is considered adequate with projected cash accruals of over Rs 22 crore against debt obligations of Rs 5 crore.
முக்கிய அம்சங்கள்
Long-term credit rating upgraded to 'CRISIL BBB-/Stable' for Rs 387.27 crore bank facilities.FY25 operating income grew to Rs 870.88 crore from Rs 646.19 crore in FY24.Net profit (PAT) increased to Rs 21.11 crore in FY25 compared to Rs 11.67 crore in FY24.Ongoing Rs 155 crore capex in Haldia for storage and refinery units, funded by Rs 75 crore debt.Interest coverage ratio improved to 2.55 times in FY25 from 2.11 times in FY24.
👀 கவனிக்க வேண்டியவை
The rating upgrade and removal from the 'non-cooperating' category signal improved corporate governance and creditworthiness. Investors should monitor the timely commissioning of the Haldia refinery in 2027, as it is a key driver for future margin expansion.
Halder Venture to Raise ₹25 Crore via Preferential Issue of 7.93 Lakh Warrants at ₹315
Halder Venture Limited is seeking shareholder approval to raise approximately ₹25 crore through the issuance of 7,93,650 convertible warrants to P.K. Bio Link Pvt. Ltd., a non-promoter entity. The warrants are priced at ₹315 each, which includes a premium of ₹305 per share. To facilitate this, the company is also proposing to increase its authorized share capital from ₹13.425 crore to ₹18.425 crore. This capital infusion is intended to support the company's growth and operational needs.
முக்கிய அம்சங்கள்
Proposed issuance of 7,93,650 convertible warrants to non-promoter P.K. Bio Link Pvt. Ltd.Total fundraise amount fixed at ₹24,99,99,750 at an issue price of ₹315 per warrant.Authorized share capital to be increased by ₹5 crore to a total of ₹18.425 crore.Warrant holders must pay 25% of the total consideration upfront, with the remaining 75% due within 18 months upon conversion.Independent valuation report determined a minimum price of ₹314.79 per equity share, supporting the ₹315 issue price.
👀 கவனிக்க வேண்டியவை
The fundraise at a premium suggests confidence from external investors; however, existing shareholders should monitor the potential equity dilution of over 5% upon warrant conversion.
Halder Venture to Raise ₹25 Crore via Preferential Issue of Convertible Warrants
Halder Venture Limited's board has approved a significant fundraise of approximately ₹25 crore through the issuance of 7,93,650 convertible warrants. These warrants are priced at ₹315 each (including a ₹305 premium) and will be allotted to P.K. Bio Link Private Limited, a non-promoter entity. To accommodate this issuance, the company is increasing its authorized share capital from ₹13.425 crore to ₹18.425 crore. Additionally, the company has transitioned its internal audit function to M/s J Kumar Jain & Associates following the resignation of the previous auditor.
முக்கிய அம்சங்கள்
Approved issuance of 7,93,650 convertible warrants at ₹315 per warrant to raise ₹24.99 crore.Authorized share capital increased from ₹13.425 crore to ₹18.425 crore to facilitate the issue.Preferential allotment targeted at a single non-promoter investor, P.K. Bio Link Private Limited.Appointment of M/s J Kumar Jain & Associates as Internal Auditor for the financial year 2025-2026.The fundraise and capital increase are subject to shareholder approval via postal ballot.
👀 கவனிக்க வேண்டியவை
Investors should view the ₹25 crore capital infusion as a positive indicator for growth and monitor the company's upcoming postal ballot for shareholder approval. The warrant pricing at ₹315 serves as a key valuation benchmark for the stock.
Halder Venture to Raise ₹25 Crore via Warrants; Increases Authorised Capital to ₹18.42 Crore
Halder Venture Limited has approved a significant fundraise of approximately ₹25 crore through the preferential issuance of 7,93,650 convertible warrants to a non-promoter entity, P.K. Bio Link Private Limited. To accommodate this and future requirements, the company is increasing its authorised share capital from ₹13.42 crore to ₹18.42 crore. The warrants are priced at ₹315 each, representing a substantial premium of ₹305 over the face value. Additionally, the company has appointed M/s J Kumar Jain & Associates as the new internal auditor for FY 2025-26.
முக்கிய அம்சங்கள்
Approved issuance of 7,93,650 convertible warrants at ₹315 per warrant, totaling ₹24.99 crore.Authorised share capital increased by ₹5 crore to a new total of ₹18.425 crore.Preferential allotment is being made to a non-promoter investor, P.K. Bio Link Private Limited.Warrant conversion price includes a premium of ₹305 per share on a face value of ₹10.Appointment of M/s J Kumar Jain & Associates as Internal Auditor following the resignation of the previous firm.
👀 கவனிக்க வேண்டியவை
Investors should view the fundraise at a significant premium as a positive indicator of valuation and growth potential. Monitor the upcoming postal ballot results for shareholder approval and subsequent updates on the utilization of these funds.
Halder Venture to Consider Fundraising via Preferential Issue on March 26, 2026
Halder Venture Limited has scheduled a Board Meeting for March 26, 2026, to deliberate on two major corporate actions. The primary agenda includes a proposal for raising funds through a preferential issue of securities, which often signals expansion or debt reduction. Additionally, the board will consider an increase in the company's authorized share capital to facilitate this issuance. Investors should note that the trading window for insiders has been closed effective March 26 until 48 hours after the meeting results are disclosed.
முக்கிய அம்சங்கள்
Board meeting scheduled for March 26, 2026, to approve fundraising via preferential issue.Proposal to increase the authorized share capital of the company to be discussed.Trading window for promoters and designated persons closed from March 26, 2026.The meeting is set to take place at the company's Kolkata office at 3:00 P.M.
👀 கவனிக்க வேண்டியவை
Investors should wait for the board meeting outcome to understand the quantum of funds being raised and the issue price. A preferential issue to strategic investors can be a positive catalyst, though it may lead to equity dilution.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
